COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,802 Articles (22,527 medRxiv, 8,275 bioRxiv)

Most recent first Previous |  Page 874: Articles 8731-8740  | Next

Genomic Characterization of Sars-Cov-2 from Islamabad Pakistan by Rapid Nanopore Sequencing
Badar, N., Ikram, A., Salman, M., Umair, M., Rehman, Z., Ahad, A., Mirza, H. a., Alam, M., Mehmood, N., aamir, U. B.
10.1101/2022.02.17.480826 — Posted: 2022-02-18
Metagenomic analysis reveals the abundance and diversity of opportunistic fungal pathogens in the nasopharyngeal tract of COVID-19 patients
Hoque, M. N., Rahman, M. S., Sarkar, M. M. H., Habib, M. A., Hossain, M. A., Khan, M. S., Islam, T.
10.1101/2022.02.17.480819 — Posted: 2022-02-18
SARS-CoV-2 has not emerged in roe, red or fallow deer in Germany or Austria during the COVID 19 pandemic
Moreira-Soto, A., Walzer, C., Czirjak, G. A., Richter, M., Marino, S. F., Posautz, A., Rodo de Yebra, P., McEwen, G. K., Drexler, J. F., Greenwood, A. D.
10.1101/2022.02.18.480872 — Posted: 2022-02-18
Preparing for the next COVID: Deep Reinforcement Learning trained Artificial Intelligence discovery of multi-modal immunomodulatory control of systemic inflammation in the absence of effective anti-microbials
Larie, D., An, G., Cockrell, C.
10.1101/2022.02.17.480940 — Posted: 2022-02-18
Relative positioning of B and T cell epitopes drives immunodominance.
Biavasco, R., De Giovanni, M.
10.1101/2022.02.17.480954 — Posted: 2022-02-18
Tensor decomposition reveals coordinated multicellular patterns of transcriptional variation that distinguish and stratify disease individuals
Mitchel, J., Gordon, M. G., Perez, R. K., Biederstedt, E., Bueno, R., Ye, C. J., Kharchenko, P.
10.1101/2022.02.16.480703 — Posted: 2022-02-18
On Correlation between Structural Properties and Viral Escape Measurements from Deep Mutational Scanning
Zhang, L., Domeniconi, G., Yang, C.-C.
10.1101/2022.02.17.480939 — Posted: 2022-02-18
Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity.
Czarna, A., Plewka, J., Kresik, L., Matsuda, A., Karim, A., Robinson, C., O Byrne, S., Cunningham, F., Georgiou, I., Pachota, M., Popowicz, G., Wyatt, P. G., Dubin, G., Pyrc, K.
10.1101/2022.02.17.480845 — Posted: 2022-02-18
Low Density Lipoprotein Receptor-Related Protein 1 (LRP1) is a host factor for RNA viruses including SARS-CoV-2
Devignot, S., Sha, T. W., Burkard, T. R., Schmerer, P., Hagelkruys, A., Mirazimi, A., Elling, U., Penninger, J. M., Weber, F.
10.1101/2022.02.17.480904 — Posted: 2022-02-18
Timeliness of reporting of SARS-CoV-2 seroprevalence results and their utility for infectious disease surveillance
Donnici, C., Ilincic, N., Cao, C., Zhang, C., Deveaux, G., Clifton, D. A., Buckeridge, D., Bobrovitz, N., Arora, R. K.
10.1101/2022.02.17.22271099 — Posted: 2022-02-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).